These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 30132351

  • 1. AA amyloidosis - Benefits and prospects of IL-6 inhibitors.
    Okuda Y.
    Mod Rheumatol; 2019 Mar; 29(2):268-274. PubMed ID: 30132351
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T, Gillmore JD, Wechalekar AD, Hawkins PN, Lachmann HJ.
    Clin Exp Rheumatol; 2015 Mar; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [Abstract] [Full Text] [Related]

  • 3. [A review for recent advances in AA amyloid research and therapeutic approach to AA amyloidosis complicating rheumatoid arthritis].
    Tamura H, Hasegawa K.
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Feb; 32(1):35-42. PubMed ID: 19252376
    [Abstract] [Full Text] [Related]

  • 4. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
    Miyagawa I, Nakayamada S, Saito K, Hanami K, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y.
    Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016
    [Abstract] [Full Text] [Related]

  • 5. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
    Okuda Y, Takasugi K.
    Arthritis Rheum; 2006 Sep; 54(9):2997-3000. PubMed ID: 16947531
    [Abstract] [Full Text] [Related]

  • 6. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M, Shiina M, Nishimoto N, Yoshizaki K, Kishimoto T, Akamatsu K.
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [Abstract] [Full Text] [Related]

  • 7. AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab.
    Hočevar A, Lestan B, Šemrl SS, Lakota K, Kojc N, Potočnik N, Tomšič M.
    Amyloid; 2013 Dec; 20(4):275-6. PubMed ID: 24106820
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M, Ando Y, Nakamura M, Yamashita T, Himeno S, Kim J, Sun X, Saito S, Tateishi T, Bergström J, Uchino M.
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. AA amyloidosis treated with tocilizumab: case series and updated literature review.
    Courties A, Grateau G, Philippe P, Flipo RM, Astudillo L, Aubry-Rozier B, Fabreguet I, Fahd W, Fain O, Guggenbuhl P, Hachulla E, Papo T, Richez C, Sibilia J, Morel J, Berenbaum F, Sellam J, Club Rhumatismes Inflammation and the REGATE Registry.
    Amyloid; 2015 Nov; 22(2):84-92. PubMed ID: 25585627
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases.
    Okuda Y, Ohnishi M, Matoba K, Jouyama K, Yamada A, Sawada N, Mokuda S, Murata Y, Takasugi K.
    Mod Rheumatol; 2014 Jan; 24(1):137-43. PubMed ID: 24261770
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Kumon Y, Hirata S, Takaoka H.
    Clin Exp Rheumatol; 2014 Jan; 32(4):501-8. PubMed ID: 24959698
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T.
    Mod Rheumatol; 2008 Jan; 18(2):109-18. PubMed ID: 18369528
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
    Cui D, Hoshii Y, Kawano H, Sugiyama S, Gondo T, Liu Y, Ishihara T.
    Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.